Integrating Addiction Treatment and HIV Services Into Primary Care Clinics in Ukraine
NCT04927091
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kyiv, Ukraine
View Trial DetailsNCT Number: NCT04794543
This is an ancillary study, thus participants will be recruited from participants in the HBS Study. This project acutely assesses the role of the e-cigarettes and vaping on lung health. The proposed work will inform the design of future studies to better understand vaping's health consequences and to test novel interventions to mitigate vaping's contribution to acute and/or chronic lung injury.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
This project is an ancillary study to the HBS Study. Inclusion Criteria for that IRB approved study are:
Exclusion criteria
for the HBS Study are:
For this ancillary, the experimental group must actively use at least one of the following: e-cigarettes, e-liquid vapes, burning leaf tobacco cigarettes, or inhaled burning leaf marijuana (cannabis). The control group will have no use of e-cigarettes or vape or active smoking in the past year.
Participants must be willing to archive data and biological samples for future use.
Exclusion from the ancillary are:
Time frame: Baseline only (at Visit 1)
Metabolomic analyses of exhaled breath condensate and gas.
Looking for future studies?
Notify MePennington Biomedical Research Center
Other
Effects of E-Cigarettes on the Lung Metabolome in People Living With HIV
Acronym: HBS Ancillary
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04927091
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kyiv, Ukraine
View Trial DetailsNCT03733093
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Kakata, Liberia
View Trial DetailsNCT01645865
AIDS, Acquired Immunodeficiency Syndrome
Nairobi, Kenya
View Trial DetailsNCT06552325
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Seattle, Washington, United States
View Trial Details